NOTICE OF UPGRADE
Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022
SEARCH LISTED COMPANY
Any AUS or NZ company
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
09 November 2025
| Name: | USCOM LIMITED (UCM) |
| ISIN: | AU000000UCM2 |
| Date of Listing: | 10 December 2003 |
Stock Exchange Status: (updated daily)
This entity is currently suspended from quotation on the Australian Securities Exchange and its securities cannot be traded on-market.Legal Status: (updated monthly)
ACN: 091 028 090ABN: 35 091 028 090
Registration Date: 23 December 1999
Capital Gains Tax (CGT) Status: (updated at least quarterly)
The securities in this entity may be suspended from quotation for reasons unrelated to its financial health or we have made the assessment that the securities still have value. If you are seeking to crystallise a capital loss on your securities, you should firstly consider whether your company is the subject of either a takeover or that you will be able to sell your securities on-market for value if the entity regains quotation. Entities in this category are reviewed monthly and it is possible that our assessment may change. If you are seeking to crystallise a capital loss on your securities, that process can be easily and quickly initiated at our online Worthless Shares facility here: https://www.delisted.com.au/sell-worthless-and-other-securities/.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
BoardRoom Australia
Level 8, 210 George Street, Sydney NSW 2000
GPO Box 3993 Sydney NSW 2001
Tel : 1300 737 760 (in Australia) +61 2 9290 9600 (International)
Fax : Within Australia: 1300 653 459 Outside Australia: +61 2 9279 0664
RegistryWebsite RegistryEmail
Expand this box to read and print
The company releases the results of its meeting. | 07/11/2025 |
The company releases a letter to shareholders where the company's acquisition proposal for Uscom Limited disappoints shareholders. Uscom's revenue declines and debts make it unsustainable, aiming to sell assets for relisting and tax loss benefits. | 31/10/2025 |
The company releases its Quarterly Activities/Appendix 4C Cash Flow Report. | 31/10/2025 |
The company will hold its annual general meeting on 27 November 2025, 2.30pm (Sydney time) at Suite 2, Level 8, 66 Clarence Street, Sydney, NSW. | 27/10/2025 |
The company will hold its general meeting at Suite 2, Level 8, 66 Clarence Street, Sydney, NSW at 3pm (Sydney time) on 7 November 2025. | 08/10/2025 |
The company has reached an agreement to sell its businesses and assets to AXO Medtech VCC of Singapore, pending shareholder approval in November 2025. This decision comes after sustained financial losses and difficulties in securing funding in Australia. The sale involves Uscom's subsidiary, Uscom Sng Pte. Ltd, which is valued at $2.591 million and holds all of Uscom's intellectual property. Uscom will transfer existing liabilities, leading to approximately $200,000 in cash assets post-sale, and the agreement awaits regulatory approvals and standard transaction conditions. | 30/09/2025 |
ASX has suspended Uscom Limited's securities from quotation due to breach of Listing Rule 12.2, based on the company's financial condition and auditor's report. The suspension will continue until ASX determines compliance with the rules and if securities can be reinstated to quotation. | 29/09/2025 |
The suspension of trading in the securities of USCOM Ltd will be lifted immediately, following the release by UCM of an announcement regarding a clarification of a recent announcement of UCM's orders. | 11/02/2020 |
The company releases a clarification to market in response to a request for further information and suspension from the ASX. Uscom is planning to increase manufacturing output by approximately 121% on 10 year average outputs to meet the anticipated demand for H2. Unit orders for the first five weeks of 2020 are up 124% compared to the first full two months of 2019 from 17 to 38 (unaudited), and prior to the Government announcement. Uscom will continue to update the market with material information as it is confirmed and will release its 4C as required. | 11/02/2020 |
The securities of USCOM Ltd will be suspended from quotation immediately under Listing Rule 17.3, pending the release of an announcement regarding a clarification of a recent announcement of UCM's orders. | 10/02/2020 |
The suspension of trading in the securities of Uscom Limited (the "Company") will be lifted immediately, following receipt of an announcement regarding a capital raising and transaction. Security Code: UCM | 20/07/2015 |
The company s pleased to announce the completion of a $1.55m Placement to professional and sophisticated investors (Placement). The company is also pleased to announce a Share Purchase Plan (SPP) to be underwritten up to $400k by Patersons Securities Limited (Patersons). The proceeds from the capital raise will be used to fund the acquisition of Thor Laboratories KFT (Thor), integration of Thor's operations into Uscom's existing operations, and for working capital. | 20/07/2015 |
The company releases its July 2015 Investor Presentation. | 20/07/2015 |
The securities of Uscom Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement regarding a capital raising and transaction. Security Code: UCM | 17/07/2015 |
listed entity carried for record purposes only | 01/07/2004 |
The company releases the results of its meeting. | 07/11/2025 |
The company releases a letter to shareholders where the company's acquisition proposal for Uscom Limited disappoints shareholders. Uscom's revenue declines and debts make it unsustainable, aiming to sell assets for relisting and tax loss benefits. | 31/10/2025 |
The company releases its Quarterly Activities/Appendix 4C Cash Flow Report. | 31/10/2025 |
The company will hold its annual general meeting on 27 November 2025, 2.30pm (Sydney time) at Suite 2, Level 8, 66 Clarence Street, Sydney, NSW. | 27/10/2025 |
The company will hold its general meeting at Suite 2, Level 8, 66 Clarence Street, Sydney, NSW at 3pm (Sydney time) on 7 November 2025. | 08/10/2025 |
The company has reached an agreement to sell its businesses and assets to AXO Medtech VCC of Singapore, pending shareholder approval in November 2025. This decision comes after sustained financial losses and difficulties in securing funding in Australia. The sale involves Uscom's subsidiary, Uscom Sng Pte. Ltd, which is valued at $2.591 million and holds all of Uscom's intellectual property. Uscom will transfer existing liabilities, leading to approximately $200,000 in cash assets post-sale, and the agreement awaits regulatory approvals and standard transaction conditions. | 30/09/2025 |
ASX has suspended Uscom Limited's securities from quotation due to breach of Listing Rule 12.2, based on the company's financial condition and auditor's report. The suspension will continue until ASX determines compliance with the rules and if securities can be reinstated to quotation. | 29/09/2025 |
The suspension of trading in the securities of USCOM Ltd will be lifted immediately, following the release by UCM of an announcement regarding a clarification of a recent announcement of UCM's orders. | 11/02/2020 |
The company releases a clarification to market in response to a request for further information and suspension from the ASX. Uscom is planning to increase manufacturing output by approximately 121% on 10 year average outputs to meet the anticipated demand for H2. Unit orders for the first five weeks of 2020 are up 124% compared to the first full two months of 2019 from 17 to 38 (unaudited), and prior to the Government announcement. Uscom will continue to update the market with material information as it is confirmed and will release its 4C as required. | 11/02/2020 |
The securities of USCOM Ltd will be suspended from quotation immediately under Listing Rule 17.3, pending the release of an announcement regarding a clarification of a recent announcement of UCM's orders. | 10/02/2020 |
The suspension of trading in the securities of Uscom Limited (the "Company") will be lifted immediately, following receipt of an announcement regarding a capital raising and transaction. Security Code: UCM | 20/07/2015 |
The company s pleased to announce the completion of a $1.55m Placement to professional and sophisticated investors (Placement). The company is also pleased to announce a Share Purchase Plan (SPP) to be underwritten up to $400k by Patersons Securities Limited (Patersons). The proceeds from the capital raise will be used to fund the acquisition of Thor Laboratories KFT (Thor), integration of Thor's operations into Uscom's existing operations, and for working capital. | 20/07/2015 |
The company releases its July 2015 Investor Presentation. | 20/07/2015 |
The securities of Uscom Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement regarding a capital raising and transaction. Security Code: UCM | 17/07/2015 |
listed entity carried for record purposes only | 01/07/2004 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 29/06/2021 | Rob Phillips | 165,579 | $0.166 | $27,453 |
| 28/06/2021 | Rob Phillips | 644,627 | $0.159 | $102,293 |
| 26/05/2021 | Xianhui Meng | 422,292 | $0.178 | $75,081 |
| 25/05/2021 | Xianhui Meng | 1,000,000 | $0.145 | $144,643 |
| 09/12/2020 | Brett Crowley | 200,000 | $0.186 | $37,274 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Rob Phillips | Chairman, CEO | 23/12/1999 |
| Brett Crowley | Non Exec Director, Company Secretary | 23/08/2018 |
| Xianhui Meng | Non Exec Director | 16/12/2019 |
| Christian Bernecker | Non Exec Director | 25/11/2011 |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Sheena Jack | Non Exec Director | 25/11/2011 | 23/08/2018 |
| David He | Director | 23/03/2016 | 23/05/2018 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2025 Investogain Pty Limited. All rights reserved.
